Author: Jean Paul Gagnon
Publisher:
ISBN:
Category : Pharmaceutical services
Languages : en
Pages : 80

View

Book Description

Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235

View

Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Author: Shane P. Desselle
Publisher: McGraw Hill Professional
ISBN: 9780071418690
Category : Medical
Languages : en
Pages : 628

View

Book Description
Editors Desselle and Zgarrick have brought together 33 contributed chapters in their endeavor to prepare pharmacy students for the realities of managing a practice. After a section on why it's important to study management in pharmacy school, coverage includes the various ins-and-outs of managing oneself (understanding stress), operations, people,

Author:
Publisher: DIANE Publishing
ISBN: 9780788104688
Category : Medical
Languages : en
Pages : 380

View

Book Description
Analyzes the costs, risks, and economic rewards of pharmaceutical R&D and the impact of public policy on both costs and returns. Examines the rapid increase in pharmaceutical R&D that began in the 1980s in the light of trends in science, technology, drug discovery, and health insurance coverage; Government regulation; product liability; market competition; Federal tax policy; and Federal support of prescription drug research. 12 appendices, including a glossary of terms.

Author: Norman V. Carroll
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781762397
Category : Medical
Languages : en
Pages : 332

View

Book Description
This comprehensive, clearly written textbook teaches pharmacy students and pharmacists the basics of financial accounting, management accounting, and finance, and equips them with the financial skills needed in pharmacy practice. The Third Edition has been thoroughly updated with new content and realistic problems that allow students to apply what they have learned. This edition presents examples from diverse practice settings, including HMO, hospital, and long-term care pharmacies. A new chapter explains how decision analysis can be used to assist and inform decision-making. The significantly revised pricing chapter provides additional consideration to demand and the interaction of unit costs, volume, demand, and price.

Author:
Publisher: World Health Organization
ISBN: 9240011870
Category : Business & Economics
Languages : en
Pages : 70

View

Book Description
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.

Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 16

View

Book Description

Author:
Publisher:
ISBN:
Category : Public health
Languages : en
Pages : 20

View

Book Description

Author: United States. Department of Health and Human Services
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 410

View

Book Description

Author: Peter J. Neumann
Publisher: Oxford University Press
ISBN: 0190492937
Category : Business & Economics
Languages : en
Pages : 537

View

Book Description
CEAs (cost-effectiveness analyses) are used by decision makers in the health sector to make enlightened evaluations and this book provides an in depth look at how to evaluate the evaluator. The book is aimed specifically at Public health specialists.